OpenAlex
PricingAboutJobs
Log inGet started
Work

Saxagliptin: A dipeptidyl peptidase-4 inhibitor ameliorates streptozotocin induced Alzheimer's disease

HTML

Year: 2013
Type: article
Source: Neuropharmacology
DOI: 10.1016/j.neuropharm.2013.04.008
Authors: Jayasankar Kosaraju, Chaitanya Chakravarthi Gali, Rizwan Basha Khatwal, Anil Dubala, Santhivardhan Chinni, R.M. Damian Holsinger, V. Subba Rao Madhunapantula, Satish Kumar Muthureddy Nataraj, Duraiswamy Basavan
Institutions: The University of Sydney, JSS Academy of Higher Education and Research, JSS Medical College and Hospital
Language: English

Topic: Alzheimer's disease research and treatments
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: saxagliptin, DPP-4 inhibitors, Alzheimer's disease, streptozotocin-induced neurotoxicity, glucagon-like peptide-1, amyloid-beta, tau phosphorylation, neuroinflammation, hippocampus, memory retention, cognitive impairment
SDG: Good health and well-being

Open Access status: closed

Funders: Bristol-Myers Squibb, AstraZeneca, Council of Scientific and Industrial Research, India, National Health and Medical Research Council
OpenAlex ID: W2004922338
FWCI: 3.273
Cites: 56
Cited by: 200
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms